(Press-News.org) Loyola researchers and collaborators have reported promising results from a novel therapeutic approach for women with estrogen-receptor-positive breast cancer.
The new approach, a new drug class called gamma secretase inhibitors (GSI), specifically inhibits Notch and shuts down critical genes and cancer cells responsible for tumor growth.
Kathy Albain, MD, FACP, who led the study, will present findings Dec. 11 during the 2014 San Antonio Breast Cancer Symposium.
Existing cancer drugs are effective in killing mature breast cancer cells. But a handful of immature breast cancer stem cells are resistant to such drugs. They survive and are responsible for tumor growth and progression. Resistance to standard therapy is a major cause of death in women with estrogen-receptor-positive breast cancer. Approximately 75 percent of breast cancers are estrogen-receptor positive.
"New treatments are desperately needed for women with estrogen-receptor-positive breast cancer who develop resistance to standard therapies," said Dr. Albain, a professor in the Department of Medicine, Division of Hematology/Oncology at Loyola University Chicago Stritch School of Medicine. "Our research suggests a potential role this new experimental drug class may have in optimizing existing endocrine therapies, such a tamoxifen and aromatase inhibitors, and in overcoming resistance to cancer drugs."
The Notch protein promotes tumor growth and survival. The protein is present on the surface of cancer stem cells. The protein latches on to other cells, and the resulting "molecular handshake" activates various genes in the stem cells that drive tumor growth, spread and survival. Activating these genes, in effect, makes the stem cells resistant to common cancer drugs. A pilot study conducted at Loyola found that the GSI appears to block this process by turning off key genes.
The purpose of the study was to identify critical genes involved in the process. The study included 20 patients with early-stage, estrogen-receptor-positive breast cancer. Prior to surgery, the patients received one of two commonly used drugs, tamoxifen or letrozole, for 14 days to block the estrogen stimulation of breast cancer cells. They underwent a biopsy on day 14. They then received the GSI, MK-0752, plus continued one of two standard drugs, tamoxifen or letrozole. Patients underwent their definitive breast cancer surgery on day 25 and part of this tumor was provided as well for this research.
Researchers discovered 18 genes that are regulated by Notch and are significantly reversed by the addition of the GSI, even though it was a very short exposure. They also identified a gene called DAXX that is critical for stem cell survival, which was turned off by the GSI.
"Identifying these genes may help us predict which patients will respond well to the GSI anti-Notch therapy," said Dr. Albain, who also is a medical oncologist and co-leader of Loyola's Breast Cancer Research Program.
There were minimal side effects reported in this study from either the GSI or the hormone therapy. One patient experienced puffy eyes and coughing and four patients experienced facial acne. No patients experienced diarrhea or surgical complications.
Researchers are planning a larger, phase II study to evaluate the efficacy of the GSI class of drugs added to endocrine therapy versus endocrine therapy alone. This study also will determine how well the 18 gene "signature" will predict who responds to therapy.
"This is an exciting new strategy to overcome resistance to a very common class of drugs (tamoxifen, letrozole), so it is our hope that in the future a vast number of patients with estrogen-receptor-positive breast cancer could benefit," Dr. Albain said.
INFORMATION:
Other investigators involved with this study include: Cheryl M. Czerlanis, Shelly Lo, Patricia A. Robinson, Ellen Gaynor, Constantine Godellas, Davide Bova, Kathy Czaplicki, Barbara Busby, Patrick J. Stiff and Clodia Osipo (senior author) from Loyola; Andrei Y. Zlobin, Kyle R. Covington, Brian T. Gallagher, Susan G. Hilsenbeck and Suzanne A.W. Fuqua from Baylor College of Medicine Duncan Cancer Center; and Lucio Miele from Louisiana State University Cancer Center.
Children exposed during pregnancy to elevated levels of two common chemicals found in the home--di-n-butyl phthalate (DnBP) and di-isobutyl phthalate (DiBP)--had an IQ score, on average, more than six points lower than children exposed at lower levels, according to researchers at Columbia University's Mailman School of Public Health.
The study is the first to report a link between prenatal exposure to phthalates and IQ in school-age children. Results appear online in the journal PLOS ONE.
DnBP and DiBP are found in a wide variety of consumer products, from dryer sheets ...
Scientists have named the first definite horned dinosaur species from the Early Cretaceous in North America, according to a study published December 10, 2014 in the open-access journal PLOS ONE by Andrew Farke from Raymond M. Alf Museum of Paleontology and colleagues.
The limited fossil record for neoceratopsian--or horned dinosaurs--from the Early Cretaceous in North America restricts scientists' ability to reconstruct the early evolution of this group. The authors of this study have discovered a dinosaur skull in Montana that represents the first horned dinosaur from ...
Nearly 269,000 tons of plastic pollution may be floating in the world's oceans, according to a study published December 10, 2014 in the open-access journal PLOS ONE by Marcus Eriksen from Five Gyres Institute and colleagues.
Microplastic pollution is found in varying concentrations throughout the oceans, but estimates of the global abundance and weight of floating plastics, both micro and macroplastic, lack sufficient data to support them. To better estimate the total number of plastic particles and their weight floating in the world's oceans, scientists from six countries ...
ANN ARBOR--As if holiday travel isn't stressful enough. Now University of Michigan researchers say we're likely sharing that already overcrowded airline cabin with countless tiny creatures including house dust mites.
"What people might not realize when they board a plane is that they can share the flight with a myriad of microscopic passengers-- including house dust mites--that take advantage of humanity's technological progress for their own benefit," said U-M biologist Pavel Klimov.
"House dust mites can easily travel on an airline passenger's clothes, skin, food ...
Massachusetts General Hospital (MGH) investigators have identified two compounds that appear, in cellular and animal models, to block the cardiac damage caused by the important chemotherapy drug doxorubicin. Their report in the Dec. 10 issue of Science Translational Medicine indicates that inhibiting the action of an enzyme that is key to the generation of cellular energy in mitochondria could prevent doxorubicin-induced damage to cardiac cells without reducing the drug's anti-tumor effects.
"Doxorubicin-induced cardiomyopathy limits the amount of the drug a patient ...
Treating the potentially blinding haze of a scar on the cornea might be as straightforward as growing stem cells from a tiny biopsy of the patient's undamaged eye and then placing them on the injury site, according to mouse model experiments conducted by researchers at the University of Pittsburgh School of Medicine. The findings, published today in Science Translational Medicine, could one day rescue vision for millions of people worldwide and decrease the need for corneal transplants.
According to the National Eye Institute, part of the National Institutes of Heath, ...
Rats that received thyroid hormones had a reduced risk for dangerous heart arrhythmias following a heart attack, according to a new study by a team of medical researchers at New York Institute of Technology.
In the NIH-funded study, published in the Journal of Cardiac Failure, the team found that thyroid hormone replacement therapy significantly reduced the incidence of atrial fibrillation - a specific kind of irregular heartbeat, or arrhythmia -- in the rats, compared to a control group that did not receive the hormones.
The finding could have important implications ...
San Diego, Calif., Dec. 10, 2014 -- Engineers at the University of California, San Diego have demonstrated a new and more efficient way to trap light, using a phenomenon called bound states in the continuum (BIC) that was first proposed in the early days of quantum wave mechanics.
Boubacar Kanté, an assistant professor in electrical and computer engineering at UC San Diego Jacobs School of Engineering, and his postdoctoral researcher Thomas Lepetit described their BIC experiment online in the rapid communication section of journal Physical Review B. The study directly ...
Researchers from North Carolina State University and Qatar University have developed a new "high-entropy" metal alloy that has a higher strength-to-weight ratio than any other existing metal material.
High-entropy alloys are materials that consist of five or more metals in approximately equal amounts. These alloys are currently the focus of significant attention in materials science and engineering because they can have desirable properties.
The NC State research team combined lithium, magnesium, titanium, aluminum and scandium to make a nanocrystalline high-entropy ...
Is it the thought that really counts?
When it comes to giving gift cards, maybe not.
New research from the University of Cincinnati can help even the most thoughtful gift giver avoid the mistake of over-personalization and keep that card from being banished to the bottom of a purse or hidden deep inside a wallet for the next six months.
"Givers often fail to anticipate that the gifts they prefer to give are not necessarily the ones recipients prefer to receive," says Mary Steffel, researcher and assistant professor of marketing in UC's Carl H. Lindner College of Business.
So ...
